Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Gaeun Kim, Soon Koo Baik

Clin Mol Hepatol. 2014;20(2):137-150. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.137

View: 9992 Download: 102 Web of Science: 8 Crossref: 12

Dong Hoo Lee

Clin Mol Hepatol. 2003;9(1):35-41. Published online January 1, 2000

View: 3122 Download: 13

Jong Hyeok Kim,Choong Kee Park

Clin Mol Hepatol. 2002;8(1):105-106. Published online January 1, 2000

View: 2299 Download: 13

Jin Mo Yang

Clin Mol Hepatol. 2001;7(4):491-493. Published online January 1, 2000

View: 1927 Download: 16

Si Hyun Bae

Clin Mol Hepatol. 2001;7(1):104-106. Published online January 1, 2000

View: 1963 Download: 14

1 |

Viewed By 5346	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5294	MAFLD: How is it different from NAFLD?
Viewed By 5191	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3885	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3840	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search